ProfileGDS4459 / ENSG00000205029
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 14% 11% 14% 22% 15% 14% 13% 16% 17% 20% 13% 13% 19% 7% 17% 10% 15% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 13.0614
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 22.9711
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 32.5714
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 43.5522
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 52.8315
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 62.8914
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 72.5813
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 82.7816
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 92.8417
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 103.1120
GSM623474group B, liver allograft wedge biopsie placebo treatment 12.7913
GSM623475group B, liver allograft wedge biopsie placebo treatment 22.5213
GSM623476group B, liver allograft wedge biopsie placebo treatment 33.0519
GSM623477group B, liver allograft wedge biopsie placebo treatment 42.777
GSM623478group B, liver allograft wedge biopsie placebo treatment 52.7817
GSM623479group B, liver allograft wedge biopsie placebo treatment 62.9410
GSM623480group B, liver allograft wedge biopsie placebo treatment 73.1715